These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 31232721)
1. Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women: A Randomized Clinical Trial. Ferrante KL; Wasenda EJ; Jung CE; Adams-Piper ER; Lukacz ES Female Pelvic Med Reconstr Surg; 2021 Feb; 27(2):112-117. PubMed ID: 31232721 [TBL] [Abstract][Full Text] [Related]
2. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Perrotta C; Aznar M; Mejia R; Albert X; Ng CW Cochrane Database Syst Rev; 2008 Apr; (2):CD005131. PubMed ID: 18425910 [TBL] [Abstract][Full Text] [Related]
3. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study. Chompootaweep S; Nunthapisud P; Trivijitsilp P; Sentrakul P; Dusitsin N Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of systemic estrogen for preventing urinary tract infections in postmenopausal women. Fox KA; Lokken EM; Reed SD; Rahn DD Menopause; 2021 May; 28(7):836-844. PubMed ID: 33973539 [TBL] [Abstract][Full Text] [Related]
5. [Prevention and treatment of recurrent urinary system infection with estrogen cream in postmenopausal women]. Xu R; Wu Y; Hu Y Zhonghua Fu Chan Ke Za Zhi; 2001 Sep; 36(9):531-3. PubMed ID: 11769665 [TBL] [Abstract][Full Text] [Related]
6. Effect of raloxifene on sexual function in postmenopausal women. Kessel B; Nachtigall L; Plouffe L; Siddhanti S; Rosen A; Parsons A Climacteric; 2003 Sep; 6(3):248-56. PubMed ID: 14567773 [TBL] [Abstract][Full Text] [Related]
7. Randomized comparison of tolterodine with vaginal estrogen cream versus tolterodine alone for the treatment of postmenopausal women with overactive bladder syndrome. Tseng LH; Wang AC; Chang YL; Soong YK; Lloyd LK; Ko YJ Neurourol Urodyn; 2009; 28(1):47-51. PubMed ID: 19089890 [TBL] [Abstract][Full Text] [Related]
8. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom. Archer DF; Kimble TD; Lin FDY; Battucci S; Sniukiene V; Liu JH J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980 [TBL] [Abstract][Full Text] [Related]
9. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Eriksen B Am J Obstet Gynecol; 1999 May; 180(5):1072-9. PubMed ID: 10329858 [TBL] [Abstract][Full Text] [Related]
10. Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy. Parsons A; Merritt D; Rosen A; Heath H; Siddhanti S; Plouffe L; Obstet Gynecol; 2003 Feb; 101(2):346-52. PubMed ID: 12576260 [TBL] [Abstract][Full Text] [Related]
11. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women. Labrie F; Cusan L; Gomez JL; Côté I; Bérubé R; Bélanger P; Martel C; Labrie C Menopause; 2009; 16(1):30-6. PubMed ID: 18820592 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on vaginal atrophy: a randomized controlled trial. Fernandes T; Costa-Paiva LH; Pedro AO; Baccaro LF; Pinto-Neto AM Menopause; 2016 Jul; 23(7):792-8. PubMed ID: 27116462 [TBL] [Abstract][Full Text] [Related]
13. Effects of preoperative local estrogen in postmenopausal women with prolapse: a randomized trial. Rahn DD; Good MM; Roshanravan SM; Shi H; Schaffer JI; Singh RJ; Word RA J Clin Endocrinol Metab; 2014 Oct; 99(10):3728-36. PubMed ID: 24947034 [TBL] [Abstract][Full Text] [Related]
14. Recurrent urinary tract infection management and prevention techniques among a population-based cohort of women. Gleicher S; Sebesta EM; Kaufman MR; Dmochowski RR; Reynolds WS Neurourol Urodyn; 2023 Nov; 42(8):1676-1685. PubMed ID: 37670465 [TBL] [Abstract][Full Text] [Related]
15. Does preoperative locally applied estrogen treatment facilitate prolapse-associated symptoms in postmenopausal women with symptomatic pelvic organ prolapse? A randomised controlled double-masked, placebo-controlled, multicentre study. Marschalek ML; Bodner K; Kimberger O; Zehetmayer S; Morgenbesser R; Dietrich W; Obruca C; Husslein H; Umek W; Koelbl H; Bodner-Adler B BJOG; 2021 Dec; 128(13):2200-2208. PubMed ID: 34464489 [TBL] [Abstract][Full Text] [Related]
16. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. Raz R; Stamm WE N Engl J Med; 1993 Sep; 329(11):753-6. PubMed ID: 8350884 [TBL] [Abstract][Full Text] [Related]
17. Local oestrogen for vaginal atrophy in postmenopausal women. Suckling J; Lethaby A; Kennedy R Cochrane Database Syst Rev; 2006 Oct; (4):CD001500. PubMed ID: 17054136 [TBL] [Abstract][Full Text] [Related]
18. Feasibility and Research Insights From a Randomized Controlled Trial for Recurrent Urinary Tract Infection Prevention in Postmenopausal Women Using Vaginal Estrogen Therapy. Lenger SM; Chu CM; Ghetti C; Durkin MJ; Jennings Z; Sutcliffe S; Lowder JL Female Pelvic Med Reconstr Surg; 2022 Jun; 28(6):e163-e170. PubMed ID: 35421017 [TBL] [Abstract][Full Text] [Related]
19. Effective Prevention of Recurrent UTIs With Vaginal Estrogen: Pearls for a Urological Approach to Genitourinary Syndrome of Menopause. Buck ES; Lukas VA; Rubin RS Urology; 2021 May; 151():31-36. PubMed ID: 32533967 [TBL] [Abstract][Full Text] [Related]